Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)
Clinical trial NCT02996214 · UNKNOWN
Trial details
- NCT number
- NCT02996214
- Sponsor
- Nanjing Luye Sike Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-12-01
- Enrollment
- 536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.